Product Description
We have established ourselves as a quality focused organization engaged in offering Viekira Pak. This medication is used for the treatments of hepatitis C virus. The medication contains four antiviral medicines called dasabuvir, ombitasvir, paritaprevir and ritonavir. We procure this medication from the most authentic vendors of the market. Viekira Pak is packed in tamper proof packaging materials to ensure safe transportation. We offer this medication at reasonable prices.
Features:
- Extended shelf life
- No fatigue after consuming
- Accurate composition
Comprehensive HCV Genotype 1 TherapyViekira Pak features a combination of four direct-acting antivirals, each targeting the Hepatitis C Virus from different angles, promoting effective viral clearance. Designed for adults with genotype 1 HCV, this oral therapy offers a robust treatment regimen recommended by healthcare professionals. The thoughtful packaging and dosage form support ease of use and adherence to therapy.
User-Friendly Weekly Pack DesignEach weekly tray of Viekira Pak contains 21 ombitasvir/paritaprevir/ritonavir tablets and 14 dasabuvir tablets, conveniently color-coded and film-coated for accurate dosing. The packaging streamlines the medication schedule, helping patients follow physician instructions consistently to maximize treatment outcomes.
Storage and Handling GuidelinesTo ensure potency and safety, Viekira Pak should be stored in its original packaging at temperatures below 30C. The product is odorless and maintains stability for up to 24 months. Patients and healthcare providers are advised to check expiry dates and keep the medication securely out of childrens reach.
FAQs of Viekira Pak:
Q: How should Viekira Pak be taken for chronic Hepatitis C infection?
A: Viekira Pak should be taken orally exactly as prescribed by your physician, usually in divided doses throughout the day. Always follow your doctors instructions regarding timing and combination of the included tablets for optimal therapeutic benefits.
Q: What is the main benefit of using Viekira Pak compared to other HCV treatments?
A: Viekira Pak uniquely combines four direct-acting antivirals, targeting the Hepatitis C Virus through multiple mechanisms. This combination increases the chance of effective viral clearance, especially for adults with genotype 1 HCV infection, as recommended in clinical guidelines.
Q: When should I start Viekira Pak therapy?
A: Viekira Pak therapy should begin only after proper diagnosis of chronic HCV genotype 1 infection and as advised by a healthcare professional. Your doctor will decide the ideal time to initiate treatment based on your medical condition and treatment history.
Q: Where should I store my Viekira Pak medication?
A: Store Viekira Pak in its original packaging at a temperature below 30C. Avoid exposure to excessive heat and moisture. Proper storage ensures the medication retains its effectiveness throughout its 24-month shelf life.
Q: What is the dosage form and appearance of Viekira Pak?
A: Viekira Pak is available as film-coated tablets in mixed colors (light pink and beige), packed in a weekly tray containing both ombitasvir/paritaprevir/ritonavir tablets and dasabuvir tablets, facilitating clear identification and proper usage.
Q: How does the packaging help with the administration process?
A: The weekly tray system in Viekira Pak organizes the medication into daily doses, reducing confusion and supporting adherence to the prescribed regimen, leading to a greater chance of successful treatment outcomes.